Parkway Cancer Centre inks partnership with CBL in Yangon, opens Myanmar’s first specialist breast clinic

The acclaimed cancer treatment organization in Singapore, Parkway Cancer Centre, has been collaborating with several forces in a bid to fight against the deadly disease. Reports released by the World Health Organization (WHO) state that cancer is one of the foremost cause behind the increasing mortality rates across the globe, based on the grounds of which the Parkway Cancer Centre has declared its agreement with the Centre for Better Living (CBL) Medical Centre and some of most noteworthy breast surgeons from Singapore. The partnership aims at enhancing cancer treatment facilities in the country, through the establishment of Myanmar’s first ever clinic for breast cancer treatment.

Parkway’s move for controlling the occurrence of breast cancer will enable the delivery of various cancer treatment therapies under a single umbrella for patients. In Myanmar, the rate of breast cancer occurrence is exceptionally high, and in addition, the lack of sufficient treatment facilities has also reflected negatively on the diagnosis.

In order to provide better treatment facilities to cancer patients, the Centre for Better Living (CBL) Breast clinic located in Yangon provides not only early and precise diagnosis, but also breast cancer screening, which would help women to decide how they would need to go about the treatment process. One of the senior consultants at the Breastcare Surgery Pte Ltd, Dr Tan Yah Yuen, was quoted stating that it is rather crucial to diagnose cancer in the early stages for effective treatment results.

As per the WHO estimates, in Myanmar, over 60,000 new cancer cases come to the fore on an annual basis. The CBL Medical Centre has undertaken noteworthy initiatives to enhance the existing lab equipment and screening technology in the country’s medical centers. Recently, it also added the mammogram machine to their lab equipment, thereby justifying that it is indeed the best facility in the country for detecting breast cancer at an early stage.